Hemofilters with different membranes and surface areas which utilize the spontaneous circulation of the blood were used to resolve fluid overload in uremic and nonuremic patients and to correct uremia in patients whose clinical conditions did not allow effective application of the usual depuration methods. Amicon D 20 and Amicon D 30 hemofilters were both effective. We improved their performance by applying a slight negative pressure on the ultrafiltrate line. The relevant hemodynamic and blood chemistry parameters were determined in all the patients to evaluate vascular stability and depuration effectiveness. In addition, a portable system was tried in one case, which allowed the patient complete mobility. Our results indicate that continuous arteriovenous hemofiltration, when vascular access consists of a Quinton-Scribner shunt, is a simple and effective method for the treatment of fluid overload resistant to pharmacologic therapy and to treat uremia in patients for whom the traditional methods of extracorporeal depuration are contraindicated.

Keywords:
Continuous hemofiltration, Ultrafiltration, Anasarca, Acute renal failure, Chronic renal failure, Portable kidney system
This content is only available via PDF.
© 1984 S. Karger AG, Basel
1984
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.